Isolation and characterization of a new antitumor antibiotic OS-3256-B from Streptomyces candidus var. azaticus.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000302:isolation & purification* / Q000494:pharmacology / Q000627:therapeutic use; D001372:Aza Compounds; D055598:Chemical Phenomena; D002621:Chemistry; D003470:Culture Media; D006367:HeLa Cells / Q000187:drug effects; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D008815:Mice, Inbred Strains; D010455:Peptides / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D012510:Sarcoma 180 / Q000188:drug therapy; D013055:Spectrophotometry, Infrared; D013056:Spectrophotometry, Ultraviolet; D013302:Streptomyces / Q000032:analysis*; D013997:Time Factors
D000903:Antibiotics, Antineoplastic; D001372:Aza Compounds; D003470:Culture Media; D010455:Peptides